The research firm Contrive Datum Insights has just recently added to its database a report with the heading global IVD Market . Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide IVD Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional manner. This expansion can be ascribed to an increase in IVD use as a result of greater testing brought on by the epidemic.

1. Contrive Datum Insights
Global Research And Consulting
A complete solution to explore all the potential aspect to
drive the growth of the business industries.

2. v
ABOUT US
Contrive Datum Insights (CDI) is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers. CDI’s experienced
team of Analysts, Researchers, and Consultants uses proprietary data sources and various
tools and techniques to gather, and analyse information. Our business offerings represent the
latest and the most reliable information indispensable for businesses to sustain a competitive
edge.
Each CDI syndicated research report covers a different sector — such as chemicals, materials,
metals & mining, pharmaceuticals, energy, automotive, food and beverages, semiconductors,
med-devices, consumer goods and information technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider scope and stratified
research methodology, our syndicated reports strive to serve the overall research requirement
of clients.

3. v
Services Offered :
 Market Intelligence & Market Opportunity
Assessment
 Market Size & Segmentation
 Market Entry Strategy
 Competitor Benchmarking
 Pricing Intelligence
 Customer Intelligence
 Sourcing Intelligence
 New-Generation Products & Technologies
 Distribution & Sales Channel Assessment

4. v
CLIENTELE:
Some of the global leading clients that we have served:

5. v
CLIENTELE:
Some of the global leading clients that we have served:

6. v
This expansion is a direct result of the epidemic-driven uptick in demand for IVDs. Growth in the market is anticipated to be
driven by the introduction of automated IVD systems into hospitals and laboratories, which will allow for quick, precise, and
error-free diagnosis. Market expansion is also being driven by the proliferation of new in vitro diagnostic (IVD) products from key
manufacturers. Molecular diagnostics used in IVD products allow for reliable and precise diagnosis.A highly sensitive molecular
test was created in May 2021 at the University of California, Berkeley. This examination utilizes chip technology that can identify
influenza A and SARS-CoV-2 antigens. Research is continuing on the feasibility of adapting this assay for use at the Point-of-Care
(POC). The industry's dynamics have changed as more companies prioritize ground-floor testing for home use. The Food and
Drug Administration also places a premium on at-home molecular diagnostic testing in 2021. The COVID-19 detection self-test kit
was introduced in March 2021 by BATM Advanced Communications Ltd. The risk of substitution is minimal because these tests
provide early disease detection. Patients may seek out non-internal options due to the high cost of these testing. Furthermore,
due to the high rate of internal substitution, competition is strong in the case of identification of novel viruses such as SARS-CoV-
2. Existing players' IVD product penetration is poor in places like APAC. Local musicians dominate the scene and offer more
affordable instrument prices. One of the primary factors pushing this industry forward is the development of portable, accurate,
and cost-effective technologies.The report covers the period from 2017 to 2030, with 2022 serving as the base year, and provides
Market Overview

7. v
By Region:
The North American market was valued at USD 35.92 billion in 2021 and is expected to continue to
dominate the global market during the forecast period. Some of the prominent factors contributing
to the region's highest share include the presence of major corporations in the region, such as
Abbott, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, and Danaher Corporation, as
well as appropriate and favorable government regulations. - Established diagnostic infrastructure and
adoption of technologically advanced diagnostic techniques.
Europe is expected to be the second dominant region in terms of in vitro diagnostics market share.
The market in Europe holds a significant share due to rising healthcare spending, well-established
infrastructure, large patient pool suffering from infectious diseases and cancer.
The Asia-Pacific market is expected to grow at the highest CAGR, especially in developing countries
such as India, South Korea, Australia, and China. Improvements in authorization and reimbursement
policies and increasing per capita healthcare spending in the region are expected to drive the market
growth in Asia Pacific during 2022-2029. For example, in April 2021, Seegene Inc. announced that it
had received export permission from the Korean Ministry of Food and Drug Safety to export its
COVID-19 mutation test to countries around the world. This license will strengthen the company's
sales and market position worldwide.

8. v
The Global IVD Market has been segmented into:
By Type:
• Instruments
• Reagents & Consumables
By Technique
• Immunodiagnostics
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Others
By Setting
• Laboratories
• Point-of-care
By Application:
• Infectious Diseases
• Cardiology
• Oncology
• Gastroenterology
• Others
By End-user
• Clinical Laboratories
• Hospitals
• Physicians’ Offices
• Others

9. v
The Global IVD Market has been segmented into:
By Region
North America
• US
• Canada
• Mexico
• Rest of North America
The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
•Latin America
• Brazil
• Argentina
• Rest of Latin America
By Region
Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
By Region
Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe

10. v
Multiple disorders, including those with a hereditary component, a cardiovascular component, and a neurological
component, are on the rise. The World Health Organization (WHO) reports that heart disease and other forms of
cardiovascular disease kill 17.9 million people per year. Overall market growth can be attributed to rising routine
diagnosis and public awareness of the need of early diagnosis. The rapid expansion of the industry is being bolstered
by the launch of novel, cutting-edge IVD products.In addition, various ailments, including hypertension, diabetes,
cardiovascular, liver, and kidney disorders, are projected to increase dramatically along with the aging population.An
article in Knoema from 2021 claims that the percentage of people 65 and older in the world was 9.5%. As a result,
the global market is expected to grow much faster than expected.Over the past decade, in vitro diagnostic devices
have undergone tremendous development and advancement thanks to the introduction of new products and the
adoption of additional design adjustments. The market's expansion has been stymied, however, by the high purchase
and maintenance prices of in vitro diagnostic equipment. In addition, only qualified personnel should use in vitro
diagnostic equipment. As a result, the device's upkeep costs rise, slowing the market's expansion as a whole.The
price tag for an RT-PCR machine averages around $15,000. As a result of the aforementioned price barriers, in vitro
diagnostic products have been slower to gain traction in some locations.
Market Dynamics:

11. v
• F. Hoffmann-La Roche Ltd (Switzerland),
• Abbott Laboratories (U.S.),
• Thermo Fisher Scientific Inc. (U.S.),
• Sysmex Corporation (Japan),
• Siemens Healthineers AG (Germany),
• BD (Becton,
• Dickinson,
• Company) (U.S.),
• Seegene Inc. (Republic of Korea),
• DiaSorin S.p.A. (Italy),
• Quest Diagnostics Incorporated (U.S.),
• Bio-Rad Laboratories, Inc. (U.S.)
MARKET PLAYERS

12. v
Customer Experiences
“Very happy with the service. Report quality as well as response time
for my custom market study was great. I am looking forward to work
with Contrive Datum Insights (CDI) in future. “
G. Luca, A+ Outsourced Marketing
“We are satisfied with research report offered by Contrive Datum
Insights (CDI) .” We appreciate your support throughout the project.”
Consulting Company (privacy requested)
"You and your team did a terrific job on this project.” CDI will be at the
top of our list in the future for market research projects.”
Europe based Fortune 500 Company (privacy requested)

13. v
Benefits of
Association
By associating with Contrive Datum Insights (CDI) , customer can enjoy following
benefits:
 One-Stop-Destination for all research needs (Syndicate and Custom Reports)
 Reduced Budget and Faster Turnaround Time
 Focused Research Team - Contrive Datum Insights (CDI) can arrange a dedicated team of
2-3 resources with 1 Research Manager , who will look after any ad-hoc needs of the client
 Dedicated Account Manager
 24/7 availability for any custom needs of the client
 Flexible Partnering Model to accommodate client’s research needs
 Access to Data-Cuts related to required Market for global region
 ▪ Industry Update on Weekly/Bi-Weekly/Monthly basis
 ▪ Market Trend Analysis on Monthly/Quarterly basis

14. v
To know more about us, please visit our website:
www.contrivedatuminsights.com
For sales queries or new topics email us on:
anna@contrivedatuminsights.com
Thank You!